(Q37629155)

English

The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies

scientific article

Statements

The minimum anticipated biological effect level (MABEL) for selection of first human dose in clinical trials with monoclonal antibodies (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit